Dispela em i wanpela tupela glukos-dipenden insulinotropik polipeptide (GIP) na glukagon-kain peptide-1 (GLP{3}}) resepta agonist agonist
Long sait bilong wanpela kaikai i no gat planti kalori na mekim wok bilong bodi i go bikpela, long wanem, ol bikpela manmeri i gat bikpela skin o skin i go bikpela tumas, ol i orait long wanpela sik i kamap long hevi bilong hevi bilong ol, em wanpela hevi i save kamap long ol bikpela manmeri i gat bikpela skin.
Na tu ol samting i kamap long wok bilong endokrin na insulin resistens long ol sikman i gat taip 2 daiabitis olsem wanpela adjunkt long kaikai na eksasais long kamapim gut glycemic kontrol.
A novel glucose-dependent insulinotropic polypeptide like peptide 1 (GLP-1) receptor agonist approved in the United States as an adjunct to diet and exercise to improve glycaemic control in adultswith type 2 diabetes and under investigation for use in chronic weight management, adverse cardiovascular events and the management of other conditions, including heart failure with preserved ejectionfraction and obesity and non-cirrhotic steatohepataitis i no gat alkohol long en.
Displei blong Prodak

analisis ripot

Ol bekim bilong kastoma

Fektri Introdaksen


Pakejing na trenspot


Ol Gutpela samting bilong mipela
Hae kwaliti, kompetitiv praes, inaf stok mo kwik delivery kompetitiv praes.
Entaprais standet na 99% klinpela sindaun.
Mipela i wokim na mipela inap givim ol gutpela samting wantaim prais bilong fektori.
Seif na hariap deliveri
1)Parcel i save go aut long 3-pela wok de bihain long yu baim. bihainim namba i stap.
2)Sekure na diskriet sipmen. ol kain kain rot bilong trenspot bilong makim bilong yu.
3)Kastom i winim mak bilong 99%
FAQ
Hot Tag: kampani tirzepataid peptide10mg 15mg 30mg 30mg 60mg 60mg, Saina kampani tirzepatide peptide10mg 15mg 30mg 60mg ol manifakta, ol saplaia, fektori







